Fig. 4From: Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathwaysMolecular characterization of the PDX models. Immunohistochemical staining for cMet and HER2, and FISH assay for Her2,cMet and FGFR2 are shown. Immuno-detectable proteins are indicated by brown staining; nuclei are counterstained in blue. Original magnification, ×200Back to article page